FilingPulse

PVCT insider transaction filings

PROVECTUS BIOPHARMACEUTICALS, INC. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-02. Screen PVCT transaction legs live →

FiledFormInsiderReported transactionsSource
2026-07-024Pershing Edward — CEO, Director, 10% ownerGrant/award (A): 45,860 (derivative) @ $0EDGAR
2026-06-304Bailey Webster — DirectorGrant/award (A): 48,917 (derivative) @ $0EDGAR
2026-06-304Lacey John III — DirectorGrant/award (A): 48,917 (derivative) @ $0EDGAR
2026-06-304Rodrigues Dominic — PRESIDENT, DirectorGrant/award (A): 45,860 (derivative) @ $0EDGAR
2026-06-054Pershing Edward — CEO, DirectorOption exercise (M) @ $0 · Option exercise (M): 9,436 (derivative) @ $0EDGAR
2026-05-294Pershing Edward — CEO, DirectorGrant/award (A) @ $0EDGAR
2026-05-264Pershing Edward — CEO, DirectorOption exercise (M) @ $0 · Option exercise (M): 32,089 (derivative) @ $0EDGAR
2026-05-154Pershing Edward — CEO, DirectorOption exercise (M) @ $0 · Option exercise (M): 22,651 (derivative) @ $0EDGAR
2026-05-074Pershing Edward — CEO, DirectorOption exercise (M) @ $0 · Option exercise (M): 18,876 (derivative) @ $0EDGAR
2026-04-294Pershing Edward — CEO, DirectorOption exercise (M) @ $0 · Option exercise (M): 30,202 (derivative) @ $0EDGAR
2026-04-064Pershing Edward — CEO, DirectorOption exercise (M) @ $0 · Option exercise (M): 33,977 (derivative) @ $0EDGAR
2026-03-264Pershing Edward — CEO, DirectorGrant/award (A) @ $0EDGAR
2026-03-204Pershing Edward — CEO, DirectorOption exercise (M) @ $0 · Option exercise (M): 49,067 (derivative) @ $0EDGAR
2026-03-164Pershing Edward — CEO, DirectorGrant/award (A) @ $0EDGAR
2026-03-064Pershing Edward — CEO, DirectorGrant/award (A) @ $0EDGAR
2026-02-274Pershing Edward — CEO, DirectorGrant/award (A) @ $0EDGAR
2026-02-234Pershing Edward — CEO, DirectorOption exercise (M) @ $0 · Option exercise (M): 47,180 (derivative) @ $0EDGAR
2026-02-234Pershing Edward — CEO, DirectorGrant/award (A) @ $0EDGAR
2026-02-174Pershing Edward — CEO, DirectorGrant/award (A) @ $0EDGAR
2026-02-114Pershing Edward — CEO, DirectorPurchase (P): 34,940 (derivative) @ $2.86EDGAR
2026-02-094Pershing Edward — CEO, DirectorGrant/award (A) @ $0EDGAR
2026-02-024Pershing Edward — CEO, DirectorOption exercise (M) @ $0 · Option exercise (M): 37,744 (derivative) @ $0EDGAR
2026-01-294Pershing Edward — CEO, DirectorGrant/award (A) @ $0EDGAR
2026-01-164Pershing Edward — CEO, DirectorOption exercise (M) @ $0 · Option exercise (M): 37,744 (derivative) @ $0EDGAR
2025-12-154Pershing Edward — CEO, DirectorGrant/award (A) @ $0EDGAR
2025-12-084Pershing Edward — CEO, DirectorGrant/award (A) @ $0EDGAR
2025-11-284Pershing Edward — CEO, DirectorGrant/award (A) @ $0EDGAR
2025-11-214Pershing Edward — CEO, DirectorGrant/award (A) @ $0EDGAR
2025-11-144Pershing Edward — CEO, DirectorGrant/award (A) @ $0EDGAR
2025-11-074Pershing Edward — CEO, DirectorGrant/award (A) @ $0EDGAR
2025-10-314Pershing Edward — CEO, DirectorGrant/award (A) @ $0EDGAR
2025-10-244Pershing Edward — CEO, DirectorGrant/award (A) @ $0EDGAR
2025-10-174Pershing Edward — CEO, DirectorOption exercise (M) @ $0 · Option exercise (M): 18,880 (derivative) @ $0EDGAR
2025-10-144Pershing Edward — CEO, DirectorGrant/award (A) @ $0EDGAR
2025-10-094Pershing Edward — CEO, DirectorGrant/award (A) @ $0EDGAR
2025-09-304Pershing Edward — CEO, DirectorOption exercise (M) @ $0 · Option exercise (M): 66,052 (derivative) @ $0EDGAR
2025-09-194Pershing Edward — CEO, DirectorOption exercise (M) @ $0 · Option exercise (M): 37,760 (derivative) @ $0EDGAR
2025-09-194Pershing Edward — CEO, DirectorGrant/award (A) @ $0EDGAR
2025-09-124Pershing Edward — CEO, DirectorGrant/award (A) @ $0EDGAR
2025-09-054Pershing Edward — CEO, DirectorGrant/award (A) @ $0EDGAR
2025-08-294Pershing Edward — CEO, DirectorOption exercise (M) @ $0 · Option exercise (M): 28,320 (derivative) @ $0EDGAR
2025-08-274Pershing Edward — CEO, DirectorGrant/award (A) @ $0EDGAR
2025-08-224Pershing Edward — CEO, DirectorOption exercise (M) @ $0 · Option exercise (M): 37,760 (derivative) @ $0EDGAR
2025-08-124Pershing Edward — CEO, DirectorOption exercise (M) @ $0 · Option exercise (M): 18,880 (derivative) @ $0EDGAR
2025-07-214Pershing Edward — CEO, DirectorOption exercise (M) @ $0 · Option exercise (M): 62,303 (derivative) @ $0EDGAR
2025-06-264Pershing Edward — CEO, DirectorOption exercise (M) @ $0 · Option exercise (M): 122,692 (derivative) @ $0EDGAR
2025-06-234Pershing Edward — CEO, DirectorOption exercise (M) @ $0 · Option exercise (M): 18,880 (derivative) @ $0EDGAR
2025-06-064Pershing Edward — CEO, DirectorGrant/award (A) @ $0EDGAR
2025-05-274Pershing Edward — CEO, DirectorGrant/award (A) @ $0EDGAR
2025-05-154Pershing Edward — CEO, DirectorGrant/award (A) @ $0EDGAR

Recent 8-K events — PROVECTUS BIOPHARMACEUTICALS, INC.

FiledFormItems reportedSource
2026-07-018-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-06-228-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-06-188-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits		EDGAR
2026-04-218-K8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2026-02-028-K5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits		EDGAR
2025-06-208-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2025-06-188-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits		EDGAR
2025-04-168-K4.01 — Changes in Registrant's Certifying Accountant
9.01 — Financial Statements and Exhibits		EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=PVCT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →